Researcher identifies a new way to treat HIV. Medical treatment that targets human proteins rather than ever-mutating viruses may one day help HIV-positive people whose bodies have built a resistance to 'cocktails' currently used to keep them healthy. Now researchers have pinpointed a protein variant that can be targeted to prevent the human immunodeficiency virus from harming HIV-positive individuals. Source 5i.
New drug capsule may allow weekly HIV treatment. Researchers have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule of dosing required for the drug cocktails used to fight the virus, the researchers say. Source 1d.
Today, the U.S. Food and Drug Administration approved Trogarzo (Ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (Heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (Multidrug resistant HIV, or MDR HIV).Trogarzo is administered intravenously once every 14 days by a trained medical professional and used in combination with other antiretroviral medications. Source 8z.